Evidence map›Paper›PMID 39372691›Full record

ArticleThe Pan African medical journal2024

Acute severe hepatitis and COVID-19: case report.

Saber Hmimass, Maryeme Kadiri, Mohamed Borahma, Fatima-Zahra Chabib, Camelia Berhili, Nawa Lagdali, Imane Ben Elbarhdadi, Fatima-Zahra Ajana

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. COVID-19 Infection, Drugs, and Liver Injury.Journal of clinical medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Saber HmimassDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Maryeme KadiriDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Mohamed BorahmaDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Fatima-Zahra ChabibDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Camelia BerhiliDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Nawa LagdaliDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Imane Ben ElbarhdadiDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.
Fatima-Zahra AjanaDepartment of Hepato-Gastroenterology C, Ibn Sina Hospital, Mohamed V University, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, caused by SARS-CoV-2, has been declared an international public health emergency. Patients with COVID-19, even without a history of liver disease, frequently present with liver test disturbances. Due to the multisystemic involvement of COVID-19, the pathogenesis of liver injury is likely to be multifactorial, involving systemic inflammation, small vessel thrombosis, hepatic hypoxia, and potential drug toxicity, ruling out direct infection of hepatocytes by SARS-CoV-2. COVID-19 can cause severe acute hepatitis. We report the case of a 25-year-old man admitted to emergency with abdominal pain who presented with acute severe liver failure before respiratory signs.

Indexed as

COVID-19Abdominal PainAcute DiseaseAdultHumansLiver Failure, AcuteMaleSeverity of Illness Indexcase reportCOVID-19severe acute hepatitis

Identifiers

PMID39372691
PMCPMC11453115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.